Intravascular hemolysis following low dose daily rifampin

Cindy E Neunert, Geeta S. Paranjape, Scott Cameron, Zora R. Rogers

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

We report two pediatric patients with rifampin-induced hemolysis following treatment with low daily dose rifampin for methicillin-resistant Staphylococcus aureus (MRSA). With the increased use of rifampin to treat MRSA, physicians should be aware that patients receiving rifampin therapy are at risk for hemolysis, even at low daily doses.

Original languageEnglish (US)
Pages (from-to)821-823
Number of pages3
JournalPediatric Blood and Cancer
Volume51
Issue number6
DOIs
StatePublished - Dec 1 2008

Fingerprint

Rifampin
Hemolysis
Methicillin-Resistant Staphylococcus aureus
Pediatrics
Physicians
Therapeutics

Keywords

  • Anemia
  • Hemolysis
  • Rifampin

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Neunert, C. E., Paranjape, G. S., Cameron, S., & Rogers, Z. R. (2008). Intravascular hemolysis following low dose daily rifampin. Pediatric Blood and Cancer, 51(6), 821-823. https://doi.org/10.1002/pbc.21709

Intravascular hemolysis following low dose daily rifampin. / Neunert, Cindy E; Paranjape, Geeta S.; Cameron, Scott; Rogers, Zora R.

In: Pediatric Blood and Cancer, Vol. 51, No. 6, 01.12.2008, p. 821-823.

Research output: Contribution to journalArticle

Neunert, CE, Paranjape, GS, Cameron, S & Rogers, ZR 2008, 'Intravascular hemolysis following low dose daily rifampin', Pediatric Blood and Cancer, vol. 51, no. 6, pp. 821-823. https://doi.org/10.1002/pbc.21709
Neunert CE, Paranjape GS, Cameron S, Rogers ZR. Intravascular hemolysis following low dose daily rifampin. Pediatric Blood and Cancer. 2008 Dec 1;51(6):821-823. https://doi.org/10.1002/pbc.21709
Neunert, Cindy E ; Paranjape, Geeta S. ; Cameron, Scott ; Rogers, Zora R. / Intravascular hemolysis following low dose daily rifampin. In: Pediatric Blood and Cancer. 2008 ; Vol. 51, No. 6. pp. 821-823.
@article{2398da234c854de7856db346ffff9933,
title = "Intravascular hemolysis following low dose daily rifampin",
abstract = "We report two pediatric patients with rifampin-induced hemolysis following treatment with low daily dose rifampin for methicillin-resistant Staphylococcus aureus (MRSA). With the increased use of rifampin to treat MRSA, physicians should be aware that patients receiving rifampin therapy are at risk for hemolysis, even at low daily doses.",
keywords = "Anemia, Hemolysis, Rifampin",
author = "Neunert, {Cindy E} and Paranjape, {Geeta S.} and Scott Cameron and Rogers, {Zora R.}",
year = "2008",
month = "12",
day = "1",
doi = "10.1002/pbc.21709",
language = "English (US)",
volume = "51",
pages = "821--823",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Intravascular hemolysis following low dose daily rifampin

AU - Neunert, Cindy E

AU - Paranjape, Geeta S.

AU - Cameron, Scott

AU - Rogers, Zora R.

PY - 2008/12/1

Y1 - 2008/12/1

N2 - We report two pediatric patients with rifampin-induced hemolysis following treatment with low daily dose rifampin for methicillin-resistant Staphylococcus aureus (MRSA). With the increased use of rifampin to treat MRSA, physicians should be aware that patients receiving rifampin therapy are at risk for hemolysis, even at low daily doses.

AB - We report two pediatric patients with rifampin-induced hemolysis following treatment with low daily dose rifampin for methicillin-resistant Staphylococcus aureus (MRSA). With the increased use of rifampin to treat MRSA, physicians should be aware that patients receiving rifampin therapy are at risk for hemolysis, even at low daily doses.

KW - Anemia

KW - Hemolysis

KW - Rifampin

UR - http://www.scopus.com/inward/record.url?scp=56749185819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56749185819&partnerID=8YFLogxK

U2 - 10.1002/pbc.21709

DO - 10.1002/pbc.21709

M3 - Article

C2 - 18680155

AN - SCOPUS:56749185819

VL - 51

SP - 821

EP - 823

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 6

ER -